Exchange: NASDAQ·Updated 07:57 PM EDT
MREO logo

MREO Mereo Biopharma

$0.25
$0.0222
(8.16%)
Today
Closed $0.25
$0.008
(3.20%)
After Hours
Reported EarningsAug 11
Mkt Cap$39.9M
Vol1.34M

About MREO

Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649). The company was founded by Denise Vera Scots-Knight, Charles Edward Sermon, Alastair Graham MacKinnon, and John P. Richard in March 10, 2015 and is headquartered in London, the United Kingdom.
47

Neutral Sentiment

How do you feel about MREO?

Advertisement|Remove ads.